Outcome predictors of uncomplicated sepsis by Ter Avest, Ewoud et al.
 
 
 University of Groningen
Outcome predictors of uncomplicated sepsis
Ter Avest, Ewoud; de Jong, Maarten; Brümmer, Ineke; Wietasch, Götz Jk; Ter Maaten, Jan C
Published in:
International journal of emergency medicine
DOI:
10.1186/1865-1380-6-9
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Ter Avest, E., de Jong, M., Brümmer, I., Wietasch, G. J., & Ter Maaten, J. C. (2013). Outcome predictors of
uncomplicated sepsis. International journal of emergency medicine, 6(1), [9]. https://doi.org/10.1186/1865-
1380-6-9
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
ter Avest et al. International Journal of Emergency Medicine 2013, 6:9
http://www.intjem.com/content/6/1/9BRIEF RESEARCH REPORT Open AccessOutcome predictors of uncomplicated sepsis
Ewoud ter Avest1*, Maarten de Jong2, Ineke Brűmmer2, Götz JK Wietasch3 and Jan C ter Maaten2Abstract
Background: The development of sepsis risk prediction models and treatment guidelines has largely been based
on patients presenting in the emergency department (ED) with severe sepsis or septic shock. Therefore, in this
study we investigated which patient characteristics might identify patients with an adverse outcome in a
heterogeneous group of patients presenting with uncomplicated sepsis to the emergency department (ED).
Findings: We performed a retrospective cohort analysis of all ED patients presenting with uncomplicated sepsis in a
large teaching hospital during a 3-month period. During this period, 70 patients fulfilled the criteria of uncomplicated
sepsis. Eight died in the hospital. Non-survivors were characterized by a higher abbreviated Mortality in Emergency
Department Sepsis (MEDS) score (7.2 ± 3.4 vs. 4.8 ± 2.9, p = 0.03) and a lower Hb (6.6 ± 1.2 vs. 7.7 ± 1.4, p = 0.03), and
they used beta-blockers more often (75% vs. 19%, p < 0.01).
Conclusions: Non-survivors of uncomplicated sepsis had on average a higher abbreviated MEDS score, a lower
hemoglobin (Hb) and more often used β-blockers compared to survivors. Early identification of these factors might
contribute to optimization of sepsis treatment for this patient category and thereby prevent disease progression to
severe sepsis or septic shock.
Keywords: Sepsis, Uncomplicated, Emergency department, OutcomeIntroduction
Sepsis remains an ongoing challenge in medicine. Mor-
tality rates depend on the sepsis stage and co-morbidity
and range from 4.1% in patients with uncomplicated
sepsis to as high as 50% in patients with septic shock [1].
Although patients with severe sepsis or septic shock
have a higher a-priori chance of having an unfavorable
outcome than patients with uncomplicated sepsis, the
latter group is responsible for the majority of sepsis hos-
pitalizations in developed countries [2]. Unfortunately,
however, research over the past years has mainly been
focused on the early identification and treatment of pa-
tients with advanced stage sepsis: Risk prediction models
and especially treatment guidelines for sepsis at the ED
are largely derived from patients presenting with severe
sepsis or septic shock, and it remains unclear whether
the same risk prediction models are applicable for pa-
tients presenting to the ED with uncomplicated sepsis
[3-5]. Therefore, the primary objective of this study was* Correspondence: teravestewoud@hotmail.com
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in any medium, provided the original work is pto investigate which patient characteristics are related to
outcome in a heterogeneous group of patients present-
ing with uncomplicated sepsis to the ED.Methods
Study design and inclusion criteria
We performed a retrospective cohort analysis of all adult
emergency department (ED) patients (>18 years) who
presented to the ED of the University Hospital
Groningen with uncomplicated sepsis during a 3-month
period (1 September 2010 until 30 November 2010).
During this period, a quality improvement initiative had
been carried out to improve early sepsis recognition in
patients with sepsis at the ED. According to this initia-
tive, for all patients visiting the ED during the study
period with sepsis (defined as the presence of two or
more SIRS criteria in combination with the suspicion of a
new infection), temperature, heart rate, respiration rate,
blood pressure and oxygen saturation were recorded at
presentation by a trained triage nurse. Ordering of
(additional) diagnostic tests and initiation of therapy
were both left completely to the discretion of the at-
tending physician.s an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
ter Avest et al. International Journal of Emergency Medicine 2013, 6:9 Page 2 of 5
http://www.intjem.com/content/6/1/9In the present retrospective cohort analysis, only pa-
tients with non-severe (i.e., uncomplicated) sepsis were
enrolled. Uncomplicated sepsis was defined retrospect-
ively by one of the authors (MdJ) as sepsis in the ab-
sence of signs of organ dysfunction at a site remote
from the site of the infection or sepsis with signs of
hypotension or hypoperfusion. Subjects were excluded
when one or more of the following criteria were met
for not to being considered to have a chronic condi-
tion: systolic blood pressure <90 mmHg, or a MAP<65
mmHg, creatinine >177 umol.l-1, bilirubin >34 mmol.l-1,
platelet count <100×109.l-1, coagulopathy with INR>1.5 or
aPTT > 60 s, or a lactate level of > 2 mmol.l-1. A limited
life expectancy as a result of underlying disease was not
an exclusion criterion in the present study.Data collection
Vital signs, biochemical test results, ED treatment charac-
teristics and final outcome were retrieved from the elec-
tronic patient files. Abbreviated Mortality in Emergency
Department sepsis (MEDS) scores [3] without neutrophil
bands [6] (since these are not routinely measured in many
Dutch hospitals) were calculated retrospectively from
eight independent predictors of mortality, resulting in a
maximum score of 24.Primary data analysis
Differences between survivors and non-survivors regard-
ing baseline characteristics were tested for statistical sig-
nificance by using the two-tailed Fisher’s exact test for
dichotomous variables and one-way ANOVA for con-
tinuous variables, with age, gender, time-to-antibiotics
and fluid administration (all variables) and MEDS score
(treatment variables) as covariates. It was estimated that
with our study population of 70 subjects, a Spearman’s
correlation coefficient (r) of 0.3 could be detected with a
power of 80% and an alpha error of 0.05.Ethics
As our study only involved retrospective evaluation of
routinely recorded patient data, this type of study was
determined to be exempt research by our local institu-
tional review board.Findings
During the 3-month period, 8,146 patients visited the
ED of the University Medical Center Groningen. During
this period, 101 patients were diagnosed with sepsis, of
which 31 had a severe sepsis or septic shock, and 70 had
an uncomplicated sepsis. Further results refer to this lat-
ter group.Clinical and biochemical characteristics at presentation
Eight patients died in-hospital after presentation to the
ED, on average 11 days after presentation (range 4–21).
Table 1 shows the clinical and biochemical characteris-
tics at presentation of survivors and non-survivors. The
non-survivors were on average 14 years older than the
survivors. Although they more often had an underlying
medical condition predisposing for sepsis, only one of
the non-survivors had a terminal illness (metastatic ma-
lignancy) with a life expectancy <1 month at the time of
presentation (Tables 1 and 2). Non-survivors more often
used beta-blockers compared to survivors, while other
vasoactive drug use and immunosuppressive drug use
were not significantly different between both groups.
Lower respiratory tract infections were the prevailing
source of sepsis in both survivors (56%) and non-
survivors (75%, p = 0.77). Hemoglobin concentration
was the only biochemical parameter that differed signifi-
cantly between survivors and non-survivors, even after
correction for the age difference between both groups.
As expected, the mean MEDS score was significantly
higher in patients with an adverse outcome compared to
survivors. None of the subjects had a MEDS score ≥12
(high-risk group).
Treatment characteristics
Table 1 shows the treatment characteristics for both sur-
vivors and non-survivors. Mean time from presentation
at the ED to the administration of the first gift of antibi-
otics was 87 min (range 15–215 minutes). The average
amount of intravenous fluids administered was 680 ±
584 ml in the first 120 min. No significant differences
regarding time to antibiotics or the amount of fluid ad-
ministration during the first 120 min at the ED were
present between survivors and non-survivors, even after
correction for the difference in MEDS score between
both groups (to correct for possible treatment differ-
ences resulting from differences in disease severity).
Association of patient characteristics with outcome
Of all clinical and biochemical variables at presenta-
tion, only beta-blocker use was correlated to outcome
with a correlation coefficient (r) larger than the mini-
mum r of 0.3 that could be detected with our study
population (r = −0.40, p < 0.001).
Discussion
In our study, we found a mortality rate of 11%, which is
higher than several previous studies reported [3,5]. It is
unlikely that the higher mortality rate in our study is the
result of the inclusion of many subjects suffering from a
terminal illness: Only 2 out of 70 subject had a terminal
illness and a resulting do-not-resuscitate status. All other
subjects received optimal care, including referral to the
Table 1 Clinical and biochemical characteristics of







n [%] n [%]
Demographics and history
Gender (M/F) 70 35/27 4/4 0.51
Age (years) 70 57 ± 19 71 ± 9 0.04
Underlying predisposing
condition for adverse course
of sepsis*
70 39 [63%] 8 [100%] 0.42
Immunocompromised state** 70 22 4 0.73
Nursing home resident 70 1 [2%] 1 [12%] 0.24
Terminal illness 70 1 [12%] 1 [12%] 0.24
Relevant medication use
Immunosuppressive drugs (n) 70 19 [31%] 1 [12%] 0.68
Maintenance antibiotics (n) 70 5 [8%] 1 [12%] 0.54
β-blockers (n) 70 12 [19%] 6 [75%] <0.01
Other vasoactive medications 70 18 [29%] 3 [38%] 0.71




70 35 6 0.77
Urinary tract infection 70 10 2 0.64




70 0 1 0.13
Heart rate (bpm) 70 109 ± 18 101 ± 19 0.34
Respiration rate (rpm) 70 24 ± 6 22 ± 5 0.14
Temperature (°C) 70 38.3 ± 1.0 37.8 ± 1.6 0.32
SBP (mmHg) 70 131 ± 26 132 ± 30 0.62
DBP (mmHg)
MAP (mmHg) 70 91 ± 16 95 ± 20 0.84
Oxygen saturation (%) 70 94 ± 4 95 ± 3 0.58
Laboratory values
Hb (mmol.l-1) 70 7.7 ± 1.4 6.6 ± 1.2 0.03
Ht (%) 70 36 ± 0.10 35 ± 0.09 0.94
Platelet count (×109.l-1) 69 251 ± 160 243 ± 179 0.77
White blood cell count
(×109.l-1)
70 13.0 ± 6.2 8.5 ± 4.7 0.06
CRP (mg.l-1) 70 110 ± 98 113 ± 90 0.90
Creatinine (umol.l-1) 70 83 ± 49 79 ± 20 0.58
BUN (mmol.l-1) 70 6.3 ± 3.3 9.2 ± 3.6 0.14
Bilirubin (mmol.l-1) 49 18 ± 21 21 ± 12 0.93
Glucose (mmol.l-1) 61 7.2 ± 2.5 6.3 ± 1.0 0.23
Arterial lactate (mmol.l-1) 45 1.1 ± 0.5 1.3 ± 0.2 0.57
Table 1 Clinical and biochemical characteristics of
survivors and non-survivors of uncomplicated sepsis at
the emergency department (Continued)
Treatment characteristics
Time to antibiotics (min) 47 88 ± 54 80 ± 51 0.85
Fluid administration first
120 min (ml)
62 688 ± 586 625 ± 627 0.89
Abbrev. MEDS score 70 4.8 ± 2.9 7.2 ± 3.4 0.03
Data are presented as mean ± SD. GCS, Glasgow coma scale; SBP, systolic
blood pressure; MAP, mean arterial pressure; Hb, hemoglobin; CRP, C-reactive
protein; BUN, blood urea nitrogen.
*See Table 2.
**Immunocompromised state was considered present if a patient had any of
the following: HIV or AIDS, leukemia, any malignancy, any history of
chemotherapy, neutropenic fever, non-Hodgkin’s lymphoma, transplanted
organ, or current use of steroid or other immunosuppressive drugs.
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that 56 out of 70 subjects in our study had co-morbidity
potentially predisposing them to an adverse course of
their sepsis, and 26 out of 70 subjects (37%) were con-
sidered immunocompromised.
Previous studies identified various patient characteris-
tics related to final outcome in patients with severe sep-
sis, and multiple risk prediction models have been
developed to adequately risk stratify patients based on
combinations of these characteristics [7]. Most com-
monly used, and the only model created to aid clinical
decision making in the ED, is the MEDS score [3]. In
our study we calculated abbreviated MEDS scores (with-
out neutrophil bands, reflecting common practice in the
Netherlands) as a measure of sepsis severity [6]. Even
though the MEDS score was <12 for all subjects in-
cluded in our study, we found that the average MEDS
score was significantly higher in subjects with an adverse
outcome [7,8], which was mainly a reflection of theTable 2 Co-morbidity of survivors and non-survivors of






n [%] n [%]
Active malignancy 7 4 0.02
-With metastasis 1 1 0.22
Status after organ transplantation 7 1 0.64
CAD or urinary tract abnormalities 6 1 0.59
Structural bile-duct abnormalities 5 0 0.54
Heart failure 11 3 0.19




Cystic fibrosis 1 0 0.89
Wegener’s granulomatosis 1 0 0.89
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however, the non-survivors differed from the survivors
also in respect to various parameters not included in
the MEDS score. First, subjects with an adverse out-
come invariably had an underlying predisposing med-
ical condition for their sepsis. Second, they more often
used beta-blockers compared to survivors. This finding
is in line with several experimental animal studies that
do report an increased overall sepsis mortality in beta-
blocker subgroups [9] despite the well-known positive
effects of beta-blockers on glucose modulation, the
host immune response and sepsis-related cardiac dys-
function [10]. This might be explained by the masking
effects of beta-blocker use on tachycardia, resulting in
underestimation of sepsis severity and lack of adequate
resuscitation. Finally, the group non-survivors had a
significantly lower Hb, even after correction for the
age difference. Theoretically, this could be explained
partially by differences in pre-hospital fluid administra-
tion, since this parameter was not recorded in the
present study. From previous studies, however [11], we
know that administration of 2 l normal saline in 1 h re-
sults in only a 7.5% decrease in Hb and Ht. So, it is
highly unlikely that pre-hospital fluid administration
alone accounts for the reported difference in Hb. Since
oxygen delivery is partially dependent on available Hb,
the lower the Hb, the earlier relative tissue hypoxia will
occur, especially in a hypermetabolic state such as sep-
sis. This finding supports the recommendation of ad-
ministration of blood in sepsis patients with a ScvO2
of less than 70% when other resuscitative methods
have already been applied [4].
In our study, the mean time to antibiotics was 87 min,
which is less than Barochia et al. [12] reported in a re-
cent meta-analysis investigating the effect of the intro-
duction of “sepsis bundles.” Fluid resuscitation in our
study was comparable to what De Miguel-Yanes et al.
[13] recently reported in an observational study of pa-
tients with uncomplicated sepsis at the ED.
Our findings are of high clinical relevance, since re-
cently Glickman et al. demonstrated that ine out of five
patients visiting the ED with uncomplicated sepsis pro-
gress to severe sepsis or even septic shock within 72 h
[14]. Early identification of risk factors creates an oppor-
tunity to tailor individual treatment in patients present-
ing with uncomplicated sepsis in order to prevent
disease progression.
Limitations
Since the prospective quality improvement initiative to
improve early sepsis recognition in patients with sepsis
at the ED ran only 3 months, only 70 subjects were in-
cluded, and a total of 8 events were recorded. This rela-
tively small sample size of our study precludes drawingsolid conclusions regarding causality: Except for beta-
blocker use, the study had insufficient power to detect
univariate correlations of outcome with age, underlying
predisposing medical condition, MEDS score, Hb and
other clinical and biochemical parameters. Future stud-
ies with larger sample sizes should therefore be carried
out to address this. As with any retrospective study, the
data included and their accuracy are dependent on the
original ED documentation. Since no formal data collec-
tion protocol was used, important data regarding treat-
ment characteristics of our patient population (e.g., time
to antibiotics and the amount of fluid and oxygen ad-
ministration) were unavailable or incomplete for a sig-
nificant number of patients at the moment of chart
review.
Conclusions
Non-survivors of uncomplicated sepsis had on average a
higher abbreviated MEDS score, a lower Hb and more
often used beta-blockers compared to survivors. Early
identification of the presence of these factors might con-
tribute to optimization of sepsis treatment for this pa-
tient category and thereby prevent disease progression
to severe sepsis or septic shock.
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